July 24, 2017 / 5:36 AM / 2 years ago

BRIEF-Evotec gets milestone payment from Bayer on endometriosis

July 24 (Reuters) - Evotec AG

* Says Evotec and Bayer advance endometriosis programme into phase I clinical development and extend alliance

* Says its multi-target endometriosis alliance with Bayer has advanced into phase I clinical development for treatment of endometriosis, triggering a milestone payment to Evotec.

* Says both companies have agreed to extend this multi-target endometriosis alliance until end of 2018 Source text for Eikon: Further company coverage: (Reporting By Georgina Prodhan)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below